Annual average increase in sales  of 0.2% ($ 26 mill. in 48 months) 2003 2007 Average annual increase in sales of 22% ($ 3...
Market information. Mar 2010-February 2011. IMS.  The total market size increased 2.7% in values Total pharmaceutical mark...
Class A08A type. Obesity and overweight Major pharmaceutical companies in Mexico Market share (%).  Units. IMS Dec-2009 Di...
A08A type. Obesity and overweight Major pharmaceutical companies in Mexico Market share (%). Values. IMS +7% Others Others...
A08A type. Obesity and overweight.  IMS. Units.  February 2011 Place  Company  Product  Market share %
A08A type. Obesity and overweight. I MS. Values.  February 2011 Place  Company  Product  Market share %
Starting date of project development  2003 Launch date:  2005 Project months 93 Accumulated total sales  US$ 37,285,465 Sa...
 
Upcoming SlideShare
Loading in...5
×

Medix English 2011 Obesity

919

Published on

MEDIX, ENGLISH, OBESITY, 2011

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
919
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Medix English 2011 Obesity

  1. 2. Annual average increase in sales of 0.2% ($ 26 mill. in 48 months) 2003 2007 Average annual increase in sales of 22% ($ 309 mill. in 51 months) March 2011 Millions of pesos Medix. Sales. MAT
  2. 3. Market information. Mar 2010-February 2011. IMS. The total market size increased 2.7% in values Total pharmaceutical market indicators 2009 February 2011 Evolution Index. Values 111 105 Evolution Index. Units 100 102 Annual sales position between laboratories (values) 39 38 Annual sales position between laboratories (units) 58 55 Part. Market (market share MS, values) 0.66% 0.71% Part. Market (market share MS, units) 0.34% 0.35% Obesity market indicators Estimated annual Market value US $ 165 million MS of anorexigenic market VS total (value) 2.4% 1.8% MS Medix anorexigenic type (values) 19.4% 29.9% MS Medix anorexigenic type (units) 22.7% 41.1% MAJOR 50 COMPANIES IN ETHICAL MARKET VALUES WITHOUT MILK
  3. 4. Class A08A type. Obesity and overweight Major pharmaceutical companies in Mexico Market share (%). Units. IMS Dec-2009 Dic - 2009 Others +18% Feb-2011 Others
  4. 5. A08A type. Obesity and overweight Major pharmaceutical companies in Mexico Market share (%). Values. IMS +7% Others Others Dec 2009 Feb 2011
  5. 6. A08A type. Obesity and overweight. IMS. Units. February 2011 Place Company Product Market share %
  6. 7. A08A type. Obesity and overweight. I MS. Values. February 2011 Place Company Product Market share %
  7. 8. Starting date of project development 2003 Launch date: 2005 Project months 93 Accumulated total sales US$ 37,285,465 Sales 2010 US$13,507,840 Obeclox project. Results.
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×